#United States #Jersey City #Data Quality #OMI Pulse #ASCO Certified

OMI Pulse Achieves ASCO Recognition

In a significant step towards improving patient-centered care, OMI Pulse has been honored as a Recognized Quality Solution (RQS) data provider for the American Society of Clinical Oncology's (ASCO) renowned program, ASCO Certified™. This designation not only showcases OMI Pulse's commitment to data quality but also marks a substantial enhancement in the ease with which oncology practices can adhere to quality measurement standards.

Understanding the ASCO Certified Program

ASCO Certified™ is a comprehensive certification program designed to support outpatient oncology practices and health systems in delivering high-quality patient care. It provides a streamlined framework for practices to evaluate various metrics such as quality outcomes and utilization measures sourced from electronic health records, insurance claims, and patient satisfaction surveys. By achieving the RQS status, OMI Pulse facilitates a smoother process for oncology practices to comply with these critical data requirements.

OMI’s Commitment to Improving Oncology Practices

Achieving recognition as a RQS data provider is not a small feat. OMI Pulse underwent a meticulous validation process to ensure that necessary data elements for clinical quality measurement were thoroughly vetted. This commitment to data quality signals to oncology practices that they have a reliable partner in OMI when it comes to maintaining high standards in patient care.

Dr. Andrew Pecora, CEO and Chairman of Outcomes Matter Innovations, expressed his enthusiasm regarding the recognition, stating, "We are thrilled that OMI Pulse is now recognized as an ASCO Recognized Quality Solution. This not only aids oncologists in submitting quality data to ASCO efficiently but also reinforces our dedication to improving care while making it more affordable."

What This Means for Oncology Practices

With the recognition as a RQS data provider, OMI Pulse is set to transform how oncology practices interact with ASCO Certified requirements. This recognition establishes a pathway for oncology practices to easily submit the necessary quality measures data while ensuring compliance with ASCO standards. The frictionless experience provided by OMI Pulse stands to make healthcare management less burdensome for oncology professionals.

The Role of OMI Pulse

Founded in 2018, OMI Pulse is dedicated to delivering innovative real-time decision support technology to specialty physicians at the point of care. In expanding its services nationally, OMI focuses on working with a diverse range of specialty physicians to craft clinical treatment pathways that address conditions with high total care costs and significant variability. By embedding this technology within existing practices, OMI aims to enhance clinical outcomes while effectively reducing unnecessary healthcare variations and overall costs.

About the Recognized Quality Solutions Initiative

The ASCO Recognized Quality Solutions (RQS) initiative is instrumental in connecting technology and data providers with oncology practices striving to meet clinical quality measures. This initiative not only recognizes excellence in data quality but also fosters a culture of compliance and streamlined certification processes among healthcare providers.

Conclusion

OMI Pulse's recent accolade as an ASCO Recognized Quality Solution provider is a meaningful advancement for the oncology community. By easing the process for oncologists to meet quality data submission requirements, OMI Pulse not only enhances the operational efficiency of practices but also underlines its unwavering commitment to improving clinical quality outcomes and affordability in patient care. As OMI continues to evolve and expand, it plays a crucial role in shaping the future of oncology by prioritizing patient-centered solutions that align with the goals of ASCO Certified standards.

For more information about OMI and their initiatives, visit their website or get in touch with their team.